Boehringer Ingelheim has released details of research presented at the 29th World Veterinary Congress which shows dogs with congestive heart failure (CHF) due to myxomatous mitral valve disease (MMVD) live longer when treated with pimobendan (Vetmedin®) compared with a commonly used ACE inhibitor.
The results of the QUEST trial, the largest international study of its kind to be conducted amongst dogs with congestive heart failure, are due to be published in the Journal of Veterinary Internal Medicine (JVIM) later this year.
The condition myxomatous mitral valve disease (MMVD) accounts for approximately 75% of all cases of CHF in dogs2. MMVD is associated with the thickening of the cusps of the mitral valve (one of the main one-way valves within the heart), affecting the flow of blood from the heart to the rest of the body. Although there is no cure for CHF due to MMVD, there are treatments available to manage the condition, improving the quality and length of the dog's life.
Professor Jens Häggström, lead investigator of the QUEST trial from the University of Uppsala, Sweden, commented that "the QUEST trial is a significant milestone in our efforts to reassure both, veterinarians and dog owners, that there is compelling evidence to show that pimobendan is an effective treatment for CHF that prolongs their dog's life and providing pet and owner with more quality time together."
The QUEST trial was a randomised, positive-controlled, multi-centre trial conducted at 28 sites across 11 countries, and is the largest study of its kind ever conducted in veterinary cardiology. The study compared a pimobendan group with a group treated with benazepril hydrochloride on top of background diuretic therapy. The trial spanned three years and followed dogs to death, euthanasia or treatment failure leading to withdrawal from the trial.
Research by Boehringer has also shown that over 50% of dog owners in the UK are unaware that their dog may be at risk of heart failure. Heart disease affects one in four dogs over seven years of age, and the lack of knowledge about this serious, life-threatening condition suggests that there is a need for better education amongst dog owners on how to recognise the disease, and how to maintain their dogs' heart health.
Vetoquinol has announced the winners of the 2008 Marbocyl Achievement Awards. Six veterinary schools took part in the award scheme, which enabled them to recognise the achievements of either staff or students, with a prize fund of £2000 for each university.
Five of the vet schools have announced their 2008 winners, the University of Liverpool will announce its winners in January 2009. Those who have already received their awards this year are:
University of Bristol Dr Catherine Fuller, MRCVSMs Kathryn Murphy, MRCVSMichael Steele, MRCVSChristopher Hudson, MRCVSSamantha Taylor, MRCVS
All of the winners are members of staff nominated by their students for excellence in teaching.
University College DublinDr Carmel Mooney, MVB MPhil PhD DECVIM-CA MRCVS, for an outstanding performance as Clinical Director of the Veterinary Hospital at UCD.
University of CambridgeAdrian Wallace, BVSc (Hons), MACVSc (SAS), MRCVS for his clinical research paper , ‘A biomechanical comparison of six double-loop configurations for use in the lateral fabella suture technique for the cranial cruciate ligament deficient canine stifle', Journal of Veterinary and Comparative Orthopaedics and Traumatology, 2008. Catherine Stalin, MA, VetMB, MRCVS for her paper ‘Radiographic morphology of the cranial portion of the cervical vertebral column in Cavalier King Charles Spaniels and its relationship to syringomyelia', American Journal of Veterinary Research, 2008 Penny Watson, MA, VetMB, CertVR, DSAM, Dip ECVIM, MRCVS, European Specialist in Small Animal Medicine for her clinical research paper ‘Prevalence and breed distribution of chronic pancreatitis at post-mortem examination in first opinion dogs' Journal of Small Animal Practice, 2007.
University of GlasgowMark Lowrie, MA VetMB MRCVS, for his Clinical Research Abstract - "Acute phase proteins and immunoglobulin A in steroid responsive meningitis-arteritis"
Royal (Dick) School of Veterinary Studies EdinburghLesa Longley, MA BVM&S Cert ZooMed MRCVS for an exceptionally high level of achievement during her residency programme.
Mark Leddy, Vetoquinol's Marketing Department Manager said: "We are delighted to have been able to help these universities recognise and reward the achievements of staff and students over the past three years."
The WSAVA's Global Nutrition Committee (GNC) has launched a Nutrition Toolkit for veterinary professionals.
The non-branded toolkit contains the following materials:
The toolkit is available for download at http://wsava.org/nutrition-toolkit.
Based on its importance to overall health, the WSAVA is campaigning to have a nutritional assessment confirmed as the fifth vital assessment in a standard physical examination and for the veterinary healthcare team to provide nutritional recommendations for each animal as an integral component of patient care.
The launch of the Nutrition Toolkit follows on from the Global Nutrition Committee's first initiative, the creation of a set of Nutrition Guidelines in 2011. These were aimed at helping veterinary professionals and pet owners ensure that pets are fed according to an optimal and individually tailored nutrition plan. According to WSAVA, they have been successful, securing endorsements from 19 veterinary organizations in 16 countries. They have been translated into ten languages and are available for download at http://www.wsava.org/guidelines/global-nutrition-guidelines.
GNC Co-Chair Dr Marge Chandler said: "Research shows that more than 90% of pet owners would like nutritional advice but fewer than 15% feel they receive it. In some parts of the world, pet malnutrition remains a major challenge, while in many other countries, pet obesity is an increasing problem. In addition, there is confusion about optimal nutrition because there is now so much conflicting and inaccurate information available online.
Our Nutrition Toolkit is designed to help the veterinary healthcare team address nutrition at every patient visit and to advance the central role of the veterinary healthcare team as the expert source of nutrition information."
The Hertfordshire-based referral centre Davies Veterinary Specialists, has announced it is to support Mission Rabies, a charity which aims to reduce the number of children in India that die as a result of contracting rabies from dogs.
According to the charity, it is estimated that at least one child dies from rabies every hour in India, normally contracted from dog bites. Mission Rabies aims to establish the country's first National Rabies Network to supply cheap, effective vaccines nationwide and monitor disease prevalence. The campaign will also include surgical training programmes in rabies danger zones, to train local vets in the best field techniques for dog population and vaccination control. The charity says it intends to vaccinate two million dogs in the key hotspot areas of India over the next three years.
Davies Veterinary Specialists is donating 50,000 rabies vaccines, to be used during the first month of the campaign, which launches this September.
VetSurgeon.org member Ian Battersby, one of Davies Veterinary Specialists' Internal Medicine team, is one of the organisers of the project, which is also supported by Dogs Trust, the World Small Animal Veterinary Association, the British Small Animal Veterinary Association and the Worldwide Veterinary Service. Ian will be travelling to India in September whilst other staff from DVS are planning various fund raising events, including marathons, evening talks to dog owners, a fund raising choir concert and an online auction to members of the veterinary profession. The auction will go live in June and lots will include in-house training seminars from members of the DVS clinical staff and gifts donated by local organisations.
DVS Managing director Clive Elwood said: "This is a very important project delivering veterinary care and expertise that will have a real impact on human lives. We are delighted to be able to help such a worthwhile cause."
Animalcare Marketing Manager, James Beaumont said: “Practice life is busier than ever and we know that practice teams are working very hard. It’s important that they are well-fuelled, so we aim to nourish their bodies and minds with our new Daxocox ‘Bitesize Lunch and Learns’. We’re simply asking practices to tell us their lunchtime desire and we’ll make sure that it’s delivered direct to their door.
"Then, in less time than it takes for them to demolish their feast, we’ll explain how breakthrough pain could be haunting their canine OA patients and, more importantly, how our new weekly NSAID, Daxocox, can help."
Practices can register for a lunch and learn and submit their lunch order by registering at www.daxocox.co.uk/lunch_learn or contacting Animalcare on 01904 487687.
Aimed at all members of the veterinary team across Europe, the webinar is moderated by veterinary nutrition expert Dottie Laflamme.
The webinar, which will also be available on demand after the event, follows others in the series that allow conversations about nutrition to be integrated into everyday consultations.
Speakers Shoshanah Verton Shaw, RVT, VTS (nutrition), and Marge Chandler (a diplomate of the American College of Veterinary Internal Medicine, the European College of Veterinary Internal Medicine and the American College of Veterinary Nutrition) will be sharing their tips for handling nutrition discussions in a non-confrontational way that preserves the client bond with the vet and the practice.
Registration for this and another three free webinars is available at https://bit.ly/purinawebinars2022.
CEVA Animal Health has added to its joint care range with the launch of Meloxidyl Injection to help control post-operative pain in cats and dogs and alleviate musculoskeletal pain in dogs.
CEVA says Meloxidyl Injection is bioequivalent to the leading meloxicam injection and dogs can be given Meloxidyl oral suspension 24 hours after Meloxidyl Injection has been administered.
Meloxidyl Injection is available in 10ml bottles containing 5mg/ml of meloxicam.
For further information, please contact your CEVA Animal Health representative or call 01494 781510.
The RCVS has been out promoting the profession, the Practice Standards Scheme (PSS) and its new 'Find a Vet' search tool to animal owners at BBC Countryfile at Blenheim Palace last week.
The RCVS stand was designed to look like a veterinary practice, complete with waiting room, consulting room, prep room, operating theatre and RCVS Accredited Practice logos.
The team from the College handed out around 1,500 ‘Find a Vet’ canvas bags containing 'Find a Vet' and Practice Standards Scheme leaflets and merchandise, and persuaded over 200 people to take part in special ‘Find a Vet’ and PSS-themed games and competitions.
These included having to find a veterinary surgeon or nurse around the showground (volunteers from RCVS Council and VN Council, including RCVS President Chris Tufnell and VN Council Chair Liz Cox, along with David Catlow, Neil Smith, his dog, Fire, Lucy Bellwood and Amber Richards).
The College reports that there was also a continual stream of children eager to pretend to be veterinary surgeons and veterinary nurses for the day and have a go at the on-stand ‘animal examination’ and ‘animal surgery’ activities. All this gave rise to plenty of photo opportunities, which parents and competition entrants were encouraged to share on social media, to help spread the word about the College’s activities.
Ian Holloway, RCVS Head of Communications said: "This was the first time the RCVS had been to such a large-scale and high-profile public event, and it provided a superb opportunity to explain to animal owners who we are and how we can help them.
"We had a great deal of interest in our new Find a Vet service, and people also seemed reassured that there was a scheme in place to accredit veterinary practices around the country. Having attended both the London Pet Show and BBC Countryfile Live this year, we now plan to increase the number of animal owner events we attend next year, to further raise public awareness of the RCVS Practice Standards Scheme and our Find a Vet service."
For more pictures of the event, see: https://flic.kr/s/aHskEQkDPc
Of the seven awards, two are dedicated to recognising veterinary surgeons and nurses who go beyond the call of duty to better the lives of animals: the Chris Laurence Vet of the Year and the Welfare Nurse of the Year.
The winners are decided by a panel of judges including Christopher Laurence MBE BVSc and James Yeates, chief veterinarian at RSPCA. This year’s winners and runners up will be honoured at a ceremony taking place on the eve of BSAVA Congress on 5th April 2017.
If there is a veterinary surgeon or nurse that you feel deserves to be recognised for their ongoing commitment to animal welfare, you can nominate them for an award at: www.cevawelfareawards.com. Entries must be in by January 13th 2017, and nominations are also accepted from members of the public.
Ceva managing director Cuneyt Seckin said: "We really have been awed and humbled by the nominations for Ceva’s Animal Welfare Awards over the past seven years and we expect this year to be no exception.
"The lengths to which some wonderful people go to ensure the health and happiness of animals across the world really knows no bounds. Not only do the awards champion people involved in animal welfare, but they also raise awareness of this important work to wider audiences."
Anyone - clients, colleagues or mentors - can nominate a young vet who they think has exceptional clinical skills, a particular passion for equine welfare or great leadership skills.
To be eligible nominees need to be members of BEVA, have graduated within the past seven years and be a registered professional with the appropriate body (eg RCVS).
BEVA Council Member Gemma Dransfield said: “We all know that one superstar who's brilliant with patients, fantastic with clients, and just an all-round legend in the making."
“This is your chance to give them the recognition they deserve.
"The BEVA One To Watch Award recognises those who are shaping the future, setting new standards in equine care, and driving the next generation of equine veterinary excellence.
"Not only will they have the glowing accolade of winning, but they will also win some career-boosting perks.”
To put an individual forward for consideration, a seconder is needed and either the nominator or seconder must be a BEVA member.
All nominations will be reviewed by a panel of experts comprising a BEVA Careers Committee representative, a senior equine vet, a non-equine veterinary professional and an external industry representative or client.
Up to five finalists will be selected and invited for a friendly online chat with the judging panel.
The winner will be announced at BEVA Congress and will be presented with a trophy, one year of BEVA membership, a fully paid BEVA Congress experience (including a one-day pass, overnight stay, and ticket to the annual dinner) and an exclusive career-boosting opportunities with BEVA to help take their career to the next level.
All finalists will receive a one-day ticket to BEVA Congress.
www.beva.org.uk/About-us/What-we-do/BEVA-Awards/One-to-watch
Genitrix has launched a new system called Osteokine, which produces Platelet-Rich-Plasma (PRP). PRP, an autologous solution containing therapeutically significant concentrations of platelets, is known to accelerate the healing of injuries and is already widely used in human medicine. It is increasingly being used in the treatment of horses.
The Osteokine system, developed by German company Orthogen which also manufactures joint therapy Irap, comprises two interconnected blood bags.
The system involves taking citrated whole blood from the horse and placing it into the first, red-capped Osteokine bag for processing in a centrifuge. The plasma and platelets are then transferred to the second bag, and a second centrifuge process separates the plasma and generates a pellet of PRP, which is extracted and used to treat the horse from which it was taken.
Treatment with PRP has been shown to accelerate wound healing in all kinds of tissue particularly tendons and ligaments and has also been used in bone healing. It has been noted to reduce perioperative traumatic pain while the higher collagen content provided by PRP can create improved scar resistance.
Commenting on the launch of the Osteokine system in the UK, Rob Watkins, Marketing Director of Genitrix, said: "Therapeutic care of equine lameness is an area of particular expertise for Genitrix and the innovative treatments we've brought to market, including Acell, HY50 and Irap already form part of the staple ‘toolkit' of many equine vets.
"The benefits of PRP in terms of accelerating wound healing and vasculerisation are already widely accepted as are the advantages of an autologous approach in terms of eliminating the risk of disease transmission. To date, however, the process of extracting PRP has proved complex and expensive and only provided in specialised laboratories.
"Osteokine, in contrast, offers a cost-effective approach based on a system which is simple to operate in practice and takes only 20 minutes. We believe it offers a highly effective approach to treating wounds and injuries in horses."
For further information on Osteokine, contact Genitrix on 01403 786345.
The BSAVA has announced a partnership with the University of Liverpool to develop a national UK disease surveillance network for companion animals.
Originally established in 2008, the Small Animal Veterinary Surveillance Network, SAVSNET, aimed to monitor the disease status of the UK small animal population (mainly dog, cat and rabbit). However, funding for the project came to an end in August 2011. At this point, BSAVA stepped in with support, as it believed that not only would the profession benefit from this source of information, but that it is in fact vital for the successful management of disease in small animals.
BSAVA President Andrew Ash said: "SAVSNET ticks all the boxes for BSAVA. High quality large scale epidemiological research helps us fulfil our obligations as a charity to public good, the information on disease surveillance gives us the information to treat animals better, and the research papers help us inform veterinary policy and education. This is an important scheme for both animal and human health."
Participation by diagnostic labs and practices is voluntary, and all data gained will be made anonymous before being reported. For more information, email savsnet@liverpool.ac.uk.
Allison Henry, product manager at Ceva Animal Health, said: "We have a very good relationship with the Royal Dick School of Veterinary Studies and it was an easy decision for us to support its students with this donation. Antimicrobial resistance is a very hot topic for human and animal health and as a manufacturer we have a duty to contribute as much as we can. Students are the next generation of veterinary surgeons and if we can educate them about antimicrobial resistance early on it will have a long term positive effect ensuring these products are used as rationally as possible and only when necessary."
Dr Tim Nuttall, head of dermatology at the Royal Dick School of Veterinary Studies, added: "We are very grateful to Ceva Animal Health for its generous support of our student research projects into antimicrobial resistance. These give our veterinary students an immensely valuable insight into the problems of antimicrobial resistance and helps them find novel approaches to counter this threat. This will not only benefit their careers but will also be of great value to vets, animals and owners throughout the world."
Ceva's efforts to support practices in their efforts to use antibiotics responsibly have continued in 2017 with the launch of GRAM (Guidance for the Rational use of AntiMicrobials), a guide on the rational use of antimicrobials in dogs and cats.
For more information on GRAM and sustainable antibiotic use, contact your local Ceva Animal Health territory manager.
The British Small Animal Veterinary Association has opened registration for next year's BSAVA / WSAVA / FECAVA Congress, offering the added incentive of some high value prizes for booking early.
Every month between now and December, everyone registered for the event will be entered into a draw. So if you book now, that gives you five chances to win:
In addition, booking early qualifies you for the Early Bird discount, and means you should secure any Masterclass and social tickets you might want.
You don't have to do anything other than register - either for yourself or for your practice - every person who pays for a registration between now and 29th December will go into the draw.
Peter Renwick, Partner, Willows Veterinary Centre said: "Given our involvement in professional development we are proud to sponsor one of the Big Booking Bonanza prizes - a complete set of the latest BSAVA Manuals that make a great addition to any interested small animal practitioner's bookshelf."
The BSAVA says that tor this WSAVA/FECAVA/BSAVA Congress there is a really broad and fascinating programme for 2012, with more for vets and nurses, plus a brilliantly expanded management programme and a new registration option for practice managers.
Visit www.bsava.com/congress for full details and terms and conditions.
US-based Life Technologies has launched a new PCR-based test system which, according to the company, allows large numbers of pigs to be screened more quickly and cost-effectively for a range of common pathogens, such as PRRSV, SIV and PCV2.
The system uses samples of oral fluids which can be obtained by leaving a cotton rope in each pen for pigs to chew on. After 20 minutes or so, the rope can be retrieved and the saliva and gingival crevicular fluid squeezed into a sample bag and represents a pooled sample from the group.
Studies have demonstrated that oral fluid samples collected in this way can form the basis of a quick and cost-effective method for screening a range of common viral pathogens. The samples were tested using a commercially available sample preparation and real-time PCR test system which can isolate and identify viral nucleic acid in a matter of hours.
For PRRS, pooled samples of oral fluids were collected from groups of experimentally infected pigs using the rope technique, along with serum samples from each individual pig on the same days. Both serum samples and oral fluids were processed using the same Applied Biosystems preparation system and real- time PCR test, both of which were supplied by Life Technologies. The results showed that PRRSV nucleic acid was detectable in both serum and oral fluid samples from the day of infection through to 40 days after infection.
For PCV2, 24 pigs that were free of PRRSV and SIV were divided into 4 pens in separate rooms, and challenged with two different virus strains (PCV2a and PVC2b) at different times. One pen acted as a (non-challenged) control. Oral fluids were collected regularly up to 140 days after initial challenge and tested using real-time PCR. High titres of PCV2 were detected from day 12 to day 28 post infection and virus was detectable throughout the entire testing period (days 2 to 98).
For SIV, a total of 180 spiked oral fluid samples were tested using real-time PCR, and subtyping reagents were also used to identify haemagglutinin and neuraminidase subtypes. The results showed that SIV nucleic acid was detectable in oral fluid samples spiked with high, medium and low copy numbers of SIV, and all positive samples could be successfully sub-typed.
Christina Boss, European Professional Service Veterinarian for Life Technologies said: "Collecting samples in this way is far less invasive for the pigs and so avoids unnecessary stress. And because all of the pigs will chew on the rope, it provides a very broad sample from the group, which is the key to assessing overall herd health. In addition, if the pooled sample provides a positive result, then the animals in that pen can be tested individually to identify those that are infected.
"These results show that the simplicity of oral fluid sampling, combined with the speed and sensitivity of a PCR-based system, provides a practical and cost- effective way of monitoring large numbers of pigs for common virus pathogens.
"The use of a semi-automated, PCR-based diagnostic system means that nucleic acid purification can be achieved in just 25 minutes and results from the real-time PCR available in 90 minutes. The molecular test is very specific and reliable, so the veterinarian can initiate individual testing as quickly as possible and make confident recommendations to the producer."
According to Life Technologies, screening for PRRS using samples of oral fluids has been gaining popularity over recent years because large numbers of pigs can be tested without increased cost or labour. The new research is due to be presented as a poster at the ESPHM meeting in Bruges in April.
XLEquine and the Animal Health Trust (AHT) have launched Plan, Prevent, Protect, billed as the UK's first equine biosecurity booklet for horse owners and yard managers to work through with their veterinary surgeon, to minimise disease risk on yards and maintain the health and welfare of the horses in their care.
Mark Tabachnik MRCVS, of XLEquine member practice Wright & Morten Veterinary Surgeons said: "For many yard and horse owners, biosecurity is just not on their radar. It only becomes important after they have had an outbreak! Strangles in particular can have devastating effects which impact not only on horse welfare, but the disruption and paralysis of animal movement has significant consequences with relationships on the yard, not to mention the financial costs in some cases.
"We wanted to develop a practical guide that pre-empts these issues by helping owners to set in place simple and in many cases common sense, plans and procedures to prevent a disease outbreak, along with practical steps should the worst happen, and an outbreak occurs.
"Our veterinary farm colleagues and the medical profession are well ahead in terms of biosecurity measures. It's about changing people's mind-sets. For example the NHS "Catch it Bin it Kill it" campaign has been highly successful in adapting our thoughts and actions towards disease spread, and consequently many of us are more aware of the importance of good biosecurity in one way or another."
Dr Richard Newton, Head of Epidemiology and Disease Surveillance at the AHT was also involved in the development of the booklet. He said: "I hope that this will encourage all equine practices to raise their game, it is so important for the whole equine community."
The booklet is available to all equine clients of XLEquine member practices, or it is available to view at http://www.xlequine.co.uk/content/plan-prevent-protect
The training sessions are taking place both online and in person and places will be allocated on a first come first served basis.
Upcoming training dates are as follows:
https://www.vetmindmatters.org/training/
Bayer Animal Health, the maker of Veraflox, has produced a new animation which explains the considerations veterinary surgeons should take into account when choosing which antibiotic to prescribe.
The animation outlines the key steps that should be taken when faced with a suspected bacterial infection and includes factors such as culture and sensitivity testing, resistance and the mutant prevention concentration.
The company says it produced the animation in response to research it carried out last year in which nearly 500 veterinary professionals (465 practising vets and 45 students) participated.
48% said they felt that not enough is being done to educate veterinary professionals on the responsible use of antibiotics and how to avoid exacerbating the urgent issue of antimicrobial resistance.
Vicky McAlister, Group Product Manager at Bayer said: "In response to this research Bayer is developing a suite of educational resources to arm vets with practical and applicable tools that help them look beyond the 'tip of the iceberg' of bacterial infections, educating about not just the clinical cure, but bacteriological cure, too."
The animation is part of a wider awareness programme entitled ‘What Lies Beneath‘ in which Bayer says it aims to better understand the challenges the veterinary industry faces when prescribing antibiotics, so that additional tools can be developed to help vets confidently use antibiotics responsibly.
The programme will also include a series of webinars led by experts in various fields including veterinary medicine, laboratory diagnostics experts, behavioural psychologists and microbiologists. The webinars are due to be released later in the year, and will present a different perspective on common issues such as compliance, how to make appropriate antimicrobial choices and the approach to and interpretation of relevant diagnostic tests.
Following stock challenges earlier in the year, the company is now urging vets to encourage farmers to vaccinate their flocks to prevent abortions during lambing.
Roy Geary, regional director for Northern Europe at Ceva Animal Health, said: “While we realise that the temporary delay of Cevac Chlamydia has been inconvenient to our valued sheep farmers we would like to thank all our customers for their patience and support during this challenging time.
"The vaccine supply is now available in the UK for the latter end of the season.
"Farmers tupping later in October should therefore be encouraged to vaccinate their flocks to protect their ewes from this devastating disease.”
www.enzooticabortion.co.uk
The Kennel Club has confirmed that the BBC has pulled out of broadcasting Crufts next year.
According to the Kennel Club, the decision was reached following what it described as 'unreasonable demands' from the BBC, including the exclusion of certain breeds of dog from the group competition at the show.
The Kennel Club says the BBC's demands took no account of the measures it has in place to improve the health of pedigree dogs, or of the fact that judges will be trained to help ensure that all dogs being awarded prizes at Crufts will be healthy representatives of their breed.
Ronnie Irving, Kennel Club Chairman, said "I am very sorry that BBC audiences around the world will not be able to join us in celebrating all dogs in 2009 and to see the remarkable diversity of dogs and activities on show at Crufts; ranging from the show classes to agility displays, the Friends for Life competition and the unsung heroes who take part in breed rescue.
"However, we have been forced to reject the insupportable conditions imposed by the BBC, who have told us they will only televise the show in 2009 if certain breeds are excluded from participating.We are unable to agree to these demands, as it would compromise both contractual obligations and our general responsibility to dog exhibitors and our audience and we believe it would be inappropriate and counterproductive to exclude any recognised breed from Crufts.
"We are obviously disappointed and confused with this outcome as we hoped the broadcast would have supported our focus on health and welfare issues, given advice about caring for and training dogs and showcased the charitable work that we support. This TV exposure would have benefited all dogs and given viewers a well-rounded picture of what the new Crufts in 2009 is all about."
In October 2008 the Kennel Club announced a strategy to show how it is focusing its activities on the health and welfare of all dogs. It announced mandatory compliance with a strict code of ethics for all breed clubs registered with the Kennel Club.
Earlier this month, it completed a review for each of the 209 pedigree dog breeds in the UK and announced revised standards that it says will have far-reaching benefits for the health and welfare of dogs. These new breed standards and health plans will benefit from research that has been funded by the Kennel Club in conjunction with veterinary research centres over a number of years. The overall aim is that all pedigree dogs should be fit for function and that breeders and judges should not reward dogs with obvious conditions or exaggerations, which would be detrimental in any way to their health.
Veterinary practices are signing up fast for the opportunity to take part in Pet Smile Month in September 2010, according to organisers.
Participating practices carry out free dental checks in September as part of a nationwide campaign to promote dental health in pets.
Pet Smile Month founder, veterinary surgeon Bob Partridge said: 'Pet Smile Month is all about relieving pain and suffering in pets and educating owners on the importance of dental care for pets. It also highlights the caring nature of the profession and provides practices with an opportunity to promote the range of services it offers.'
Registered practices will receive information leaflets to give to clients, and an educational poster - illustrating the problems of dental disease and encouraging clients to seek dental care.
For Pet Smile Month 2010, as well as the Pet Smile Art Competition (with prizes for young clients), Kruuse has offered the iM3 42-12 dental scaler as a prize for the best waiting room Pet Smile Month display, together with runner-up prizes.
Pet Smile Month could not exist without the long-standing commitment of Petosan, Genitrix, CEVA, Kruuse, NVS, Centaur, Dunlops, Veterinary Surgeons' Supply Company and IGP UK Ltd.
To find a participating local veterinary practice, owners can use the 'Find-a-PSM-Vet' button at http://www.petsmile.org/. There is also a dedicated vet area on the website.
Improve International has announced the launch of a new master's degree designed to enable veterinary surgeons in general practice to achieve a higher qualification without taking excessive time out of their practice.
The Master's Degree in Advanced Veterinary Practice Sciences is the result of a collaboration between Improve International, which delivers the taught clinical modules, the European School of Veterinary Postgraduate Studies (ESVPS), which acts as the assessment partner and Harper Adams University, which offers guidance on the research-based modules and provides validation and academic regulation under the QAA Framework.
Candidates for the new qualification can select modules from a wide range of species and discipline subjects based around their areas of special interest. They must complete at least two clinical programmes from a range of ten subjects and undertake a research module based on their clinical work.
David Babington, MRCVS and Managing Director of Improve International, said: "The launch of this new Masters is a big step forward for the concept of lifelong learning in our profession. Candidates can spend five or even ten years working towards this higher qualification with achievable 'stepping stones' along the way.
"Their studies will equip them with new skills, give them the latest veterinary knowledge and help enhance their ability to provide a superb clinical service to their clients. During the journey they have the opportunity to achieve a respected, valuable and recognised PgC (60 academic credits); a PgD (120 academic credits) and, finally, a full Masters Degree (180 academic credits)."
Dr Erica Martin, Senior Lecturer in Veterinary Nursing at Harper Adams, said: "We are delighted to be collaborating with Improve International and ESVPS on this innovative new qualification. We welcome the opportunity to help the profession increase 'evidence-based' veterinary practice through clinical development and the advancement of research skills in a way that is both accessible to vets in practice and that leads to a qualification that recognises the commitment and work involved. These postgraduate qualifications join the MSc in Veterinary Physiotherapy, the MSc in Veterinary Pharmacy and the MSc in Veterinary Nursing which are delivered by Harper Adams University."
David added: "Candidates can spread the cost of the Masters across the training period and recoup the investment easily by implementing new services they learn within the practice. The initial response to this unique qualification has been very positive with our first candidates embarking on their studies during November 2013."
For further information or to register, email enquiries@improve-international.com; visit www.improvecpd.com or call 01793 759159.
Eli Lilly and Company, which owns Elanco Animal Health, has announced an agreement to acquire Novartis Animal Health for approximately $5.4 billion in cash.
Lilly says that on completion of the deal, Elanco will be the second-largest animal health company in terms of global revenue. It will also solidify its number two ranking in the U.S., and improve its position in Europe and the rest of the world.
As part of the agreement, Lilly will acquire Novartis Animal Health's nine manufacturing sites, six dedicated research and development facilities, a global commercial infrastructure with a portfolio of approximately 600 products, a pipeline with more than 40 projects in development, and an experienced team of more than 3,000 employees.
The transaction is expected to be completed by the end of the first quarter of 2015, subject to clearance under the U.S. Hart-Scott-Rodino Antitrust Improvements Act, similar requirements outside the U.S., and other customary closing conditions.
John C. Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer said: "Animal health continues to represent an attractive growth opportunity for Lilly. We intend to keep Elanco and to take advantage of the substantial synergies between our animal health and human health businesses.
"Significant investments in our animal health business in recent years have enabled Elanco to double its revenue since 2008, leading the industry in growth. Global trends suggest continued sustained demand for animal health products in the years ahead. Through this acquisition, which moves Elanco to top-tier in the industry, we intend to create value for our shareholders by adding to our promising pipeline of innovative animal health assets, increasing sales through a larger commercial footprint, and improving efficiencies and lowering costs."